Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the …

2 days ago · CHICAGO, January 08, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have …

TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians …

May 31, 2025 · Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

5 days ago · Tempus is a public company based in Chicago (United States), founded in 2015 by Eric Lefkofsky. It operates as an AI-based precision medicine solutions for oncology. Tempus has raised …

Feb 25, 2025 · Tempus operates at the intersection of artificial intelligence and healthcare, employing machine learning to process complex biological datasets. Its platform provides clinicians with …

Launched in the United States in 2015, Tempus is now one of the largest sequencers of cancer patients in the world. Having built its platform for oncology, it has expanded to neuropsychiatry, cardiology, …

Our operational management system, Tempus, is designed for real-time management, tracking, and routing of equipment, ensuring seamless operations and swift response to service needs.

For clinicians associated with advanced research initiatives, Tempus provides next-generation genomic profiling, biological organoid modeling, image/pattern AI recognition, and a range of clinical trial and …